Gene · 57794
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PABPN1 aggregation is driven by Ala expansion and poly(A)-RNA binding, leading to CFIm25 sequestration that impairs alternative polyadenylation. | J Biol Chem | 2023 | 37422193 | PubTator, text mining | PubMed |
| HydRA: Deep-learning models for predicting RNA-binding capacity from protein interaction association context and protein sequence. | Mol Cell | 2023 | 37421941 | PubTator, text mining | PubMed |
| Circular RNA circ-FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing GLI2 mRNA. | Cancer Sci | 2023 | 37417427 | PubTator, text mining | PubMed |
| Identification of RNA-binding proteins' direct effects on gene expression via the degradation tag system. | RNA | 2023 | 37414463 | PubTator, text mining | PubMed |
| Emerging concepts involving inhibitory and activating RNA functionalization towards the understanding of microcephaly phenotypes and brain diseases in humans. | Front Cell Dev Biol | 2023 | 37408531 | PubTator, text mining | PubMed |
| A novel polypeptide CAPG-171aa encoded by circCAPG plays a critical role in triple-negative breast cancer. | Mol Cancer | 2023 | 37408008 | PubTator, text mining | PubMed |
| CRIC-seq protocol for in situ profiling of proximal RNA-RNA contacts associated with RNA-binding proteins. | STAR Protoc | 2023 | 37405924 | PubTator, text mining | PubMed |
| Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN. | Nat Commun | 2023 | 37402719 | PubTator, text mining | PubMed |
| Targeted high-throughput mutagenesis of the human spliceosome reveals its in vivo operating principles. | Mol Cell | 2023 | 37402368 | PubTator, text mining | PubMed |
| Biomolecular phase separation in stress granule assembly and virus infection. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37401177 | PubTator, text mining | PubMed |
| The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cells. | Proc Natl Acad Sci U S A | 2023 | 37399401 | PubTator, text mining | PubMed |
| A portable and intelligent logic detector for simultaneous and in-situ detection of Al3+ and fluoride in groundwater. | J Hazard Mater | 2023 | 37392640 | PubTator, text mining | PubMed |
| Base editor screens for in situ mutational scanning at scale. | Mol Cell | 2023 | 37390819 | PubTator, text mining | PubMed |
| Skipper analysis of eCLIP datasets enables sensitive detection of constrained translation factor binding sites. | Cell Genom | 2023 | 37388912 | PubTator, text mining | PubMed |
| Predictors of Lethality, Remodeling, and Aorta-Related Events in Different Types of Proximal Aortic Dissection Surgery. | Sovrem Tekhnologii Med | 2023 | 37388755 | PubTator, text mining | PubMed |
| Roles of circRNA dysregulation in esophageal squamous cell carcinoma tumor microenvironment. | Front Oncol | 2023 | 37384299 | PubTator, text mining | PubMed |
| Data mining identifies novel RNA-binding proteins involved in colon and rectal carcinomas. | Front Cell Dev Biol | 2023 | 37384253 | PubTator, text mining | PubMed |
| Small-molecule Ro-08-2750 interacts with many RNA-binding proteins and elicits MUSASHI2-independent phenotypes. | RNA | 2023 | 37369529 | PubTator, text mining | PubMed |
| Mutant KRAS Mediates circARFGEF2 Biogenesis to Promote Lymphatic Metastasis of Pancreatic Ductal Adenocarcinoma. | Cancer Res | 2023 | 37363990 | PubTator, text mining | PubMed |
| Prognostic Value of IMP3 and Its Role as an Epithelial-Mesenchymal Transition Promoter in Breast Carcinoma. | Indian J Surg Oncol | 2023 | 37363710 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57794/papers?page=31